Figure (Zynrelef 01)
Zynrelef
Product Images NDC 47426-504
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 86 technical images submitted to the FDA as part of the official labeling for Zynrelef (NDC 47426-504). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Heron Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Zynrelef 02)
Chemical Structure (Zynrelef 03)
Figure 1 (Zynrelef 04)
The text describes the NRS-A pain intensity score with mean and standard error for three different groups treated with ZYNRELEF, Bupivacaine HCI, and Saline Placebo respectively. The data is represented in a graph that shows the pain intensity score at different hours post-study drug administration.*
Figure 2 (Zynrelef 05)
Figure 3 (Zynrelef 06)
Figure (Zynrelef 07)
Figure (Zynrelef 08)
Figure (Zynrelef 09)
Figure (Zynrelef 10)
Figure (Zynrelef 11)
Figure (Zynrelef 12)
Figure (Zynrelef 13)
Figure (Zynrelef 14)
Figure (Zynrelef 15)
Figure (Zynrelef 16)
Figure (Zynrelef 17)
Figure (Zynrelef 18)
Figure (Zynrelef 19)
Figure (Zynrelef 20)
Figure (Zynrelef 21)
Figure (Zynrelef 22)
Figure (Zynrelef 23)
Figure (Zynrelef 24)
Figure (Zynrelef 25)
Figure (Zynrelef 26)
This text suggests that when assembling or replacing components, it is important not to use substitutes for any of the original parts. This is likely a safety precaution to ensure the proper functioning of the machine or device in question.*
Figure (Zynrelef 27)
Figure (Zynrelef 28)
Figure (Zynrelef 29)
Figure (Zynrelef 30)
Figure (Zynrelef 31)
Figure (Zynrelef 32)
Figure (Zynrelef 33)
Figure (Zynrelef 34)
Figure (Zynrelef 35)
Figure (Zynrelef 36)
Figure (Zynrelef 37)
Figure (Zynrelef 38)
Figure (Zynrelef 39)
Figure (Zynrelef 40)
Figure (Zynrelef 41)
Figure (Zynrelef 42)
Figure (Zynrelef 43)
Figure (Zynrelef 44)
Figure (Zynrelef 45)
This is a warning message advising not to replace any of the parts or components.*
Figure (Zynrelef 46)
Figure (Zynrelef 47)
Figure (Zynrelef 48)
Figure (Zynrelef 49)
Figure (Zynrelef 50)
Figure (Zynrelef 51)
Figure (Zynrelef 52)
Figure (Zynrelef 53)
Figure (Zynrelef 54)
Figure (Zynrelef 55)
Figure (Zynrelef 56)
Figure (Zynrelef 57)
Figure (Zynrelef 58)
Figure (Zynrelef 59)
Figure (Zynrelef 60)
Figure (Zynrelef 61)
Figure (Zynrelef 62)
Figure (Zynrelef 63)
Figure (Zynrelef 64)
This text is readable and the description would be: "This text provides a warning not to substitute any of the components."*
Figure (Zynrelef 65)
Figure (Zynrelef 66)
Figure (Zynrelef 67)
Figure (Zynrelef 68)
Figure (Zynrelef 69)
Figure (Zynrelef 70)
Figure (Zynrelef 71)
Figure (Zynrelef 72)
Figure (Zynrelef 73)
Figure (Zynrelef 74)
Figure (Zynrelef 75)
Figure (Zynrelef 76)
Figure (Zynrelef 77)
Figure (Zynrelef 78)
Figure (Zynrelef 79)
Figure (Zynrelef 80)
Figure (Zynrelef 81)
Figure (Zynrelef 82)
Principal Display Panel (14 mL Vial Carton Kit)
Principal Display Panel (10.5 mL Vial Carton Kit)
Principal Display Panel (7 mL Vial Carton Kit)
Principal Display Panel (2.3 mL Vial Carton Kit)
ZYNRELEF is a solution for soft tissue or periarticular instillation use that contains 50 mg bupivacaine and 1.8 mg meloxicam. This single-dose application package includes a 23 mL vial and sterile syringe with an Luer Lock, cap, and applicator. The kit must be used as instructed, and unused portion must be discarded. Storage instructions mandate storing the kit from 2°C to 25°C. This text also includes batch and manufacturing information, along with prescribing and dosage instruction warnings.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
